Down-regulation of SORL1 is associated with Alzheimer's disease through activating ABC transporter pathway

Zhiqiang Wei,Xingdi Qi,Shijun Zhai,Yan Chen,Xiaoshuang Xia,Boyu Zheng,Xugang Sun,Guangming Zhang,Ling Wang,Qi Zhang,Chen Xu,Shihe Jiang,Xiulian Li,Bingxin Xie,Xiaohui Liao,Zhu Ai,Xin Li

DOI: https://doi.org/10.1515/znc-2019-0213

2021-01-01

Abstract:Alzheimer's disease (AD) is a common neuro-degenerative disease with high morbidity among elderly people. A genetic attribution has been extensively proved. Here, we propose to further prioritize genes that harbor single nucleotide variation (SNV) or structural variation (SV) for AD and explore the underlying potential mechanisms through exploiting their expression and methylation spectra. A high-confidence AD-associated candidate gene list was obtained from the ClinVar and Human Gene Mutation Database (HGMD). Genome-wide methylation and expression profiles of AD and normal subjects were downloaded from the Gene Expression Omnibus (GEO). Through comprehensive comparison of expression and methylation levels between AD and normal samples, as well as different stages of AD samples, SORL1 was identified as the most plausible gene for AD incidence and progression. Gene Set Enrichment Analysis (GSEA) revealed significant activation of the ABC (ATP binding cassette) transporter with the aberrant up-regulation of SORL1 within AD samples. This study unfolds the expression and methylation spectra of previously probed genes with SNV or SV in AD for the first time, and reports an aberrant activation of the ABC transporter pathway that might contribute to AD progression. This should shed some light on AD diagnosis and precision treatment.